Literature DB >> 7241951

[Disease-specific renal failure in angioimmunoblastic lymphadenopathy - remission by high dose prednisolone. A case report (author's transl)].

E Platzer, R von Roemeling, B Kaduk, U Meinl.   

Abstract

The case of a 64 years old male with angioimmunoblastic lymphadenopathy (AIL) is reported, who developed disease specific infiltration of the kidneys with progressive destruction of renal parenchyma leading to high grade renal insufficiency. This unusual organ manifestation of AIL has not been previously reported. By treatment with high dose prednisolone and intense supportive therapy the patient underwent complete remission of AIL with preservation of the remaining renal function. Clinical, laboratory and immunological data are given as well as a light and electron microscopic evaluation of the renal involvement.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7241951     DOI: 10.1007/bf01696213

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  28 in total

1.  Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease.

Authors:  R J Lukes; B H Tindle
Journal:  N Engl J Med       Date:  1975-01-02       Impact factor: 91.245

2.  [Nature, prognosis and nomenclature of angioimmunoblastic lymphadenopathy (lymphogranulomatosis X or T-zone-lymphoma)].

Authors:  K Donhuijsen; L D Leder
Journal:  Dtsch Med Wochenschr       Date:  1979-06-15       Impact factor: 0.628

3.  Letter: Pathogenesis of vascular proliferation in angio-immunoblastic lymphadenopathy with dysproteinaemia.

Authors:  R C Graham
Journal:  Lancet       Date:  1974-09-14       Impact factor: 79.321

4.  Angioimmunoblastic lymphadenopathy with dysproteinemia.

Authors:  L R Matz; J M Papadimitriou; J R Carroll; A L Barr; R L Dawkins; J M Jackson; R P Herrmann; B K Armstrong
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

5.  Immunoblastic lymphadenopathy. A report of two cases.

Authors:  J I Spector; S Miller
Journal:  JAMA       Date:  1977-09-19       Impact factor: 56.272

6.  Angioimmunoblastic lymphadenopathy: an ultrastructural and immunologic study with review of the literature.

Authors:  R S Neiman; P Dervan; C Haudenschild; R Jaffe
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

7.  [Angio-immunoblastic lymphadenopathy].

Authors:  C G Schmidt
Journal:  Dtsch Med Wochenschr       Date:  1978-09-29       Impact factor: 0.628

8.  Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course.

Authors:  G Frizzera; E M Moran; H Rappaport
Journal:  Am J Med       Date:  1975-12       Impact factor: 4.965

9.  Angioimmunoblastic lymphadenopathy with dysproteinemia. A pathogenetic link between lymphoid proliferation and malignant lymphoma.

Authors:  A Z Bluming; H G Cohen; A Saxon
Journal:  Am J Med       Date:  1979-09       Impact factor: 4.965

10.  Lung involvement in angioimmunoblastic lymphadenopathy (ail).

Authors:  C J Zylak; R Banerjee; P A Galbraith; D S McCarthy
Journal:  Radiology       Date:  1976-12       Impact factor: 11.105

View more
  3 in total

1.  Angioimmunoblastic T-cell lymphoma and membranous nephropathy: a still unreported association.

Authors:  Masaru Togashi; Hideki Wakui; Koya Kodama; Yoshihiro Kameoka; Atsushi Komatsuda; Takashi Nimura; Ryo Ichinohasama; Ken-Ichi Sawada
Journal:  Clin Exp Nephrol       Date:  2010-02-23       Impact factor: 2.801

2.  Delayed diagnosis of Angioimmunoblast T-cell lymphoma presenting with type II Cryoglobulinemia and acute kidney injury: a case report and narrative review of the literature.

Authors:  Xiang-Yang Li; Hai-Yan He; Shu-Ling Yue; Pearl Pai
Journal:  BMC Nephrol       Date:  2020-11-07       Impact factor: 2.388

Review 3.  Renal infarction due to polyarteritis nodosa in a patient with angioimmunoblastic T-cell lymphoma: a case report and a brief review of the literature.

Authors:  Maria Raffaella Ambrosio; Bruno Jim Rocca; Alessandro Ginori; Monica Onorati; Alberto Fabbri; Mario Carmellini; Stefano Lazzi; Sergio Tripodi
Journal:  Diagn Pathol       Date:  2012-05-08       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.